Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
Revenue (Most Recent Fiscal Year) | $132.58M |
Net Income (Most Recent Fiscal Year) | $-1.54M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | 43.40 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 2.91 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.29 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 35.98 |
Pre-Tax Margin (Trailing 12 Months) | 7.07% |
Net Margin (Trailing 12 Months) | 3.99% |
Return on Equity (Trailing 12 Months) | 8.06% |
Return on Assets (Trailing 12 Months) | 5.11% |
Current Ratio (Most Recent Fiscal Quarter) | 4.84 |
Quick Ratio (Most Recent Fiscal Quarter) | 3.97 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.24 |
Inventory Turnover (Trailing 12 Months) | 1.98 |
Book Value per Share (Most Recent Fiscal Quarter) | $8.48 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.00 |
Earnings per Share (Most Recent Fiscal Year) | $0.16 |
Diluted Earnings per Share (Trailing 12 Months) | $0.38 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 14.24M |
Free Float | 12.97M |
Market Capitalization | $401.60M |
Average Volume (Last 20 Days) | 0.04M |
Beta (Past 60 Months) | 1.01 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 8.90% |
Percentage Held By Institutions (Latest 13F Reports) | 96.63% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |